ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Multiple myeloma treatment granted Orphan Drug Designation
September 19, 2019Orphan Drug Designation has been given to bispecific antibody candidate, GBR 1342, for the treatment of multiple myeloma. -
Glenmark Launches CD38xCD3 Phase 1 Trial for Bispecific Antibody GBR 1342
November 10, 2018Glenmark Pharmaceuticals announced the decision to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342. The decision is driven by recent findings derived from a non-interventional human study utilizing a clinically validat
Pharma Sources Insight January 2025
